Nothing Special   »   [go: up one dir, main page]

GB202318384D0 - An orally disintegrating tablet containing amlodipine or pharmaceutically acceptable salts thereof and the process of preparing the same - Google Patents

An orally disintegrating tablet containing amlodipine or pharmaceutically acceptable salts thereof and the process of preparing the same

Info

Publication number
GB202318384D0
GB202318384D0 GBGB2318384.1A GB202318384A GB202318384D0 GB 202318384 D0 GB202318384 D0 GB 202318384D0 GB 202318384 A GB202318384 A GB 202318384A GB 202318384 D0 GB202318384 D0 GB 202318384D0
Authority
GB
United Kingdom
Prior art keywords
preparing
pharmaceutically acceptable
acceptable salts
same
orally disintegrating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2318384.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novumgen Ltd
Original Assignee
Novumgen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novumgen Ltd filed Critical Novumgen Ltd
Priority to GBGB2318384.1A priority Critical patent/GB202318384D0/en
Publication of GB202318384D0 publication Critical patent/GB202318384D0/en
Pending legal-status Critical Current

Links

GBGB2318384.1A 2023-12-01 2023-12-01 An orally disintegrating tablet containing amlodipine or pharmaceutically acceptable salts thereof and the process of preparing the same Pending GB202318384D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2318384.1A GB202318384D0 (en) 2023-12-01 2023-12-01 An orally disintegrating tablet containing amlodipine or pharmaceutically acceptable salts thereof and the process of preparing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2318384.1A GB202318384D0 (en) 2023-12-01 2023-12-01 An orally disintegrating tablet containing amlodipine or pharmaceutically acceptable salts thereof and the process of preparing the same

Publications (1)

Publication Number Publication Date
GB202318384D0 true GB202318384D0 (en) 2024-01-17

Family

ID=89507807

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2318384.1A Pending GB202318384D0 (en) 2023-12-01 2023-12-01 An orally disintegrating tablet containing amlodipine or pharmaceutically acceptable salts thereof and the process of preparing the same

Country Status (1)

Country Link
GB (1) GB202318384D0 (en)

Similar Documents

Publication Publication Date Title
MX2020012965A (en) Pharmaceutical combination, composition and compound preparation comprising glucokinase activator and dpp-iv inhibitor, and preparation method and use thereof.
EP1803446A4 (en) Orally disintegrating tablet and method of preparation
MD3892302T2 (en) Compositions containing Ibrutinib
CO6551722A2 (en) COMPOSITIONS AND PHARMACEUTICAL TABLETS WITH COATING OR COMPRESSIBLE AND MANUFACTURING METHODS
HUP0101336A2 (en) Process for the preparation of perindopril and their pharmaceutically acceptable salts
WO2006065277A3 (en) Heterocyclic aspartyl protease inhibitors
EP3981399A4 (en) Oral solid tablet comprising bruton's tyrosine kinase inhibitor and preparation method therefor
HUP0401941A2 (en) Pharmaceutical formulation comprising a proton pomp inhibitor and antacids and process for its preparation
IL162105A (en) INDOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS FOR INHIBITION OF FACTOR Xa
NO322892B1 (en) Galantamine hydrobromide tablet and process for its preparation.
MY126555A (en) Oral pharmaceutical extended release dosage form
MY145637A (en) Capecitabine pediatric tablets
WO2009043926A3 (en) Oral fast disintegrating tablets
EP1622586A4 (en) Process for preparing tannate tablet capsule or other solid dosage forms
WO2003026623A8 (en) Intraorally disintegrating valdecoxib compositions
DK1523303T3 (en) Medicines containing vardenafil hydrochloride trihydrate and their methods of preparation
WO2010070449A3 (en) Highly pure laquinimod or a pharmaceutically acceptable salt thereof
FI4101454T3 (en) Compositions for use in the treatment of hypertension
BR112017013253A2 (en) oral disintegrating tablets, process for producing oral disintegrating tablet containing tofacitinib or pharmaceutically acceptable salts thereof, process for producing oral disintegrating tablet, disintegrant, and sweeteners
GB202318384D0 (en) An orally disintegrating tablet containing amlodipine or pharmaceutically acceptable salts thereof and the process of preparing the same
GB202219356D0 (en) An orally disintegrating tablet containing gabapentin or pharmaceutically acceptable salts thereof and the process of preparing the same
WO2003086319A3 (en) Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactant
EP4206191A4 (en) Pharmaceutically acceptable salt of cariprazine and crystal form thereof, and preparation method therefor and use thereof
GB202216584D0 (en) An orally disintegrating tablet containing atorvastatin and process of preparing the same
GB202318473D0 (en) An orally disintegrating tablet of paroxetine and its process of preparation